Table 3 Summary of results for primary and secondary outcomes.
Primary outcome: cerebral NIRS | 30° Median (IQR) | 60° Median (IQR) | p value | |
---|---|---|---|---|
Period 1 | rSO2 (%) | 67 (54.5–75) | 68 (59.5–73) | 0.882 |
FTOE | 0.3 (0.19–0.39) | 0.28 (0.23–0.36) | 0.882 | |
Period 2 | rSO2 (%) | 62 (58.5–71.5) | 69 (63–78) | 0.331 |
FTOE | 0.33 (0.25–0.37) | 0.23 (0.17–0.36) | 0.37 | |
Period 3 | rSO2 (%) | 63 (54.5–71) | 68 (57–75) | 0.412 |
FTOE | 0.3 (0.24–0.39) | 0.29 (0.22–0.39) | 0.603 | |
Period 4 | rSO2 (%) | 70 (63–75) | 66 (59–72.5) | 0.603 |
FTOE | 0.28 (0.23–0.34) | 0.28 (0.23–0.33) | 1 |
Secondary outcomes: Peripheral oxygen saturations (SpO2) and Heartrate (HR) | 30° Median (IQR) | 60° Median (IQR) | p value | |
---|---|---|---|---|
Period 1 | SpO2 (%) | 95 (94–99) | 94 (92–95.5) | 0.295 |
HR (bpm*) | 157 (141–164) | 154 (149–163) | 0.941 | |
Period 2 | SpO2 (%) | 94 (92–97.5) | 95 (92–98) | 0.603 |
HR (bpm) | 154 (147–160) | 161 (148–163) | 0.37 | |
Period 3 | SpO2 (%) | 94 (90–97.5) | 95 (92–98) | 0.766 |
HR (bpm) | 153 (146–156.5) | 155 (149–160) | 0.503 | |
Period 4 | SpO2 (%) | 96 (94–98) | 95 (90.5–97) | 0.37 |
HR (bpm) | 154 (146–157) | 153 (144.5–161.5) | 0.941 |
Secondary outcomes: Numbers of babies with Bradycardia or Desaturations | 30° | 60° | Both angles | |
---|---|---|---|---|
Significant Bradycardic episodes (n = 10) | 6 | 2 | 2 | |
Significant Desaturation episodes (n = 6) | 3 | 1 | 2 |